echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Neurology: Morphological and functional comparison of postganglionic ultrasonography to help early identification of multiple system atrophy (MSA-P) and Parkinson's disease (PD)!

    Neurology: Morphological and functional comparison of postganglionic ultrasonography to help early identification of multiple system atrophy (MSA-P) and Parkinson's disease (PD)!

    • Last Update: 2022-03-05
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    "Parkinson's disease" defines a number of clinical symptoms, mainly associated with motor symptoms such as rigidity, tremors and bradykinesia
    .


    This includes primary Parkinson's disease (PD), as well as other more rare syndromes with different pathogenesis, prognosis and response to drug therapy, such as multiple system atrophy (MSA)


     "Parkinson's Syndrome"

    Parkinson's disease affects about 2% of people over the age of 65
    .


    Lack of disease-modifying treatments can lead to severe disability, placing a heavy burden on health systems worldwide


    Diagnosis of autonomic disturbances is often the main symptom in patients with Parkinson's syndrome and can be traced back many years before motor symptoms are fully developed


    We assessed prospective morphological and functional autonomic assist involvement in patients with early (within 2 years of motor onset) MSA-P and PD to identify possible biomarkers that may help Biomarkers for early identification of these two diseases


    The study included 100 patients with Parkinson's disease within 2 years of the onset of motor symptoms
    .


    At recruitment, nonmotor, autonomic, and small fiber symptoms were assessed by questionnaires, and postganglionic hypersonic function was assessed by dynamic sweat test and distal needle skin biopsy


    At recruitment, nonmotor, autonomic, and small fiber symptoms were assessed by questionnaires, and postganglionic hypersonic function was assessed by dynamic sweat test and distal needle skin biopsy


    • Fifty-seven PD patients (m/f = 36/21, age 63.
      5 ± 9.
      4 years) and 43 MSA-P patients (m/f = 27/16, age 62.
      3 ± 9.
      0 years) were included in the study
      .
    • Clinical scales and questionnaires showed that MSA-P patients had more severe clinical symptoms than PD patients
      .
    • Sweat volume and intraepidermal, hair motor, and supramotor densities were lower in both groups compared to controls, but were greater in MSA-P patients
      .
    • Hair motor nerve and hyperlong motor nerve density are associated with sweating function and non-motor clinical symptoms
      .
    • The arithmetic product of sweat production times sweat fiber density was defined, effectively separating the two populations, with an area under the receiver operating characteristic curve of 0.
      83
      .
  • Fifty-seven PD patients (m/f = 36/21, age 63.
    5 ± 9.
    4 years) and 43 MSA-P patients (m/f = 27/16, age 62.
    3 ± 9.
    0 years) were included in the study
    .
  • Clinical scales and questionnaires showed that MSA-P patients had more severe clinical symptoms than PD patients
    .
  • Sweat volume and intraepidermal, hair motor, and supramotor densities were lower in both groups compared to controls, but were greater in MSA-P patients
    .
  • Hair motor nerve and hyperlong motor nerve density are associated with sweating function and non-motor clinical symptoms
    .
  • The arithmetic product of sweat production times sweat fiber density was defined, effectively separating the two populations, with an area under the receiver operating characteristic curve of 0.
    83
    .
  • The arithmetic product of sweat production times sweat fiber density was defined, effectively separating the two populations, with an area under the receiver operating characteristic curve of 0.
    83
    .


         The dynamic sweat test and quantification of cutaneous autonomic nerves provide a sensitive morphofunctional approach to assess components of the postganglionic sweat neural pathway, revealing a more severe involvement in MSA-P than PD early in the disease process
    .


    This method can be used to distinguish the two cases early


    The dynamic sweat test and quantification of cutaneous autonomic nerves provide a sensitive morphofunctional approach to assess components of the postganglionic sweat neural pathway, revealing a more severe involvement in MSA-P than PD early in the disease process


    Source: Provitera V, Iodice V, Manganelli F, et al.


    Provitera V, Iodice V, Manganelli F, et al.
    Postganglionic Sudomotor Assessment in Early Stage of Multiple System Atrophy and Parkinson Disease: A Morpho-functional Study [published online ahead of print, 2022 Jan 11].
    Neurology.
    2022;10.
    1212/WNL .
    0000000000013300.
    doi:10.
    1212/WNL.
    0000000000013300 leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.